Severe hypersensitivity to the active substance or to any of the excipients.
Breast feeding (see Use in Pregnancy & Lactation).
Severe bone marrow depression prior to starting first course, as evidenced by baseline neutrophils <1.5 x 109/l and/or a platelet count of <100 x 109/l.
Other Services
Country
Account